Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard S Oster

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Frontiers in Oncology|September 30, 2024
How we diagnose Myelodysplastic syndromesHoward S Oster, Moshe Mittelman
Mediterranean Journal of Hematology and Infectious Diseases|July 14, 2018
Thrombocytopenia in Patients with Myelodysplastic Syndromes: Still an Unsolved ProblemMay Basood, Howard S Oster, Moshe Mittelman
Leukemia Research|June 25, 2010
The lower risk MDS patient at risk of rapid progressionMoshe Mittelman, Howard S Oster, Michael Hoffman, et al.
Leukemia Research|May 15, 2012
Erythropoietin: the swinging pendulumHoward S Oster, Drorit Neumann, Michael Hoffman, et al.
Haematologica|October 24, 2024
Diagnosis of myelodysplastic syndromes: the classic and the novelHoward S Oster, Arjan A Van de Loosdrecht, Moshe Mittelman
Frontiers in Medicine|July 28, 2025
Neutropenia (even mild) and anemia are poor prognostic factors in myelodysplastic syndromesReut Hausman, Roi Gat, Noa Goldschmidt, et al.
Journal of Clinical Medicine|March 10, 2022
Serum Hypoalbuminemia Is a Long-Term Prognostic Marker in Medical Hospitalized Patients, Irrespective of the Underlying DiseaseHoward S Oster, Yardenna Dolev, Orli Kehat, et al.
Acta Haematologica|July 15, 2020
Erythropoietin Treatment Is Associated with Decreased Blood Glucose Levels in Hematologic PatientsHoward S Oster, Moran Gvili Perelman, Albert Kolomansky, et al.
The Israel Medical Association Journal : IMAJ|August 16, 2013
Mortality in heart failure with worsening anemia: a national studyHoward S Oster, Michal Benderly, Michael Hoffman, et al.
The Israel Medical Association Journal : IMAJ|January 27, 2004
Anemia as a risk factor for ischemic heart diseaseAliza Zeidman, Zinaida Fradin, Anetta Blecher, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Frontiers in Oncology|September 30, 2024
How we diagnose Myelodysplastic syndromesHoward S Oster, Moshe Mittelman
Mediterranean Journal of Hematology and Infectious Diseases|July 14, 2018
Thrombocytopenia in Patients with Myelodysplastic Syndromes: Still an Unsolved ProblemMay Basood, Howard S Oster, Moshe Mittelman
Leukemia Research|June 25, 2010
The lower risk MDS patient at risk of rapid progressionMoshe Mittelman, Howard S Oster, Michael Hoffman, et al.
Leukemia Research|May 15, 2012
Erythropoietin: the swinging pendulumHoward S Oster, Drorit Neumann, Michael Hoffman, et al.
Haematologica|October 24, 2024
Diagnosis of myelodysplastic syndromes: the classic and the novelHoward S Oster, Arjan A Van de Loosdrecht, Moshe Mittelman
Frontiers in Medicine|July 28, 2025
Neutropenia (even mild) and anemia are poor prognostic factors in myelodysplastic syndromesReut Hausman, Roi Gat, Noa Goldschmidt, et al.
Journal of Clinical Medicine|March 10, 2022
Serum Hypoalbuminemia Is a Long-Term Prognostic Marker in Medical Hospitalized Patients, Irrespective of the Underlying DiseaseHoward S Oster, Yardenna Dolev, Orli Kehat, et al.
Acta Haematologica|July 15, 2020
Erythropoietin Treatment Is Associated with Decreased Blood Glucose Levels in Hematologic PatientsHoward S Oster, Moran Gvili Perelman, Albert Kolomansky, et al.
The Israel Medical Association Journal : IMAJ|August 16, 2013
Mortality in heart failure with worsening anemia: a national studyHoward S Oster, Michal Benderly, Michael Hoffman, et al.
The Israel Medical Association Journal : IMAJ|January 27, 2004
Anemia as a risk factor for ischemic heart diseaseAliza Zeidman, Zinaida Fradin, Anetta Blecher, et al.
Pageof 4